Does INFLIXIMAB Cause Inappropriate schedule of product administration? 6,847 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6,847 reports of Inappropriate schedule of product administration have been filed in association with INFLIXIMAB (Renflexis). This represents 4.9% of all adverse event reports for INFLIXIMAB.
6,847
Reports of Inappropriate schedule of product administration with INFLIXIMAB
4.9%
of all INFLIXIMAB reports
119
Deaths
1,687
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From INFLIXIMAB?
Of the 6,847 reports, 119 (1.7%) resulted in death, 1,687 (24.6%) required hospitalization, and 82 (1.2%) were considered life-threatening.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 6,847 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Product use issue (12,752)
Drug intolerance (11,173)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
ACETAMINOPHEN (2,248)
Which INFLIXIMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT